Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 6,586,000
  • Shares Outstanding, K 29,600
  • Annual Sales, $ 2,068 M
  • Annual Income, $ 28,130 K
  • 36-Month Beta 0.88
  • Price/Sales 3.20
  • Price/Cash Flow 57.69
  • Price/Book 2.44

Price Performance

See More
Period Period Low Period High Performance
1-Month
218.16 +1.83%
on 06/15/17
230.40 -3.58%
on 06/09/17
+1.18 (+0.53%)
since 05/26/17
3-Month
195.50 +13.64%
on 03/31/17
230.40 -3.58%
on 06/09/17
+21.75 (+10.85%)
since 03/24/17
52-Week
135.94 +63.43%
on 06/27/16
230.40 -3.58%
on 06/09/17
+83.47 (+60.18%)
since 06/24/16

Most Recent Stories

More News
Bio-Rad (BIO) Scores a Strong Buy Right Now: Here's How

Bio-Rad Laboratories, Inc. (BIO) has rallied 12.9% over the last three months, ahead of the S&P 500's 4.3% gain.

AXDX : 29.35 (-2.98%)
BIO : 222.03 (-0.21%)
ALGN : 152.81 (-0.45%)
INGN : 95.18 (+1.12%)
Health Care Battle Rages On: 2 MedTech Stocks to Buy

Let's focus on two MedTech Stocks which are fundamentally strong amidst the volatile market condition.

PAHC : 37.85 (+0.53%)
BIO : 222.03 (-0.21%)
Capital Senior Living (CSU) in Focus: Stock Moves 5.8% Higher

Capital Senior Living Corporation (CSU) was a big mover last session, as the company saw its shares rise almost 6% on the day.

CSU : 15.63 (-0.51%)
BIO : 222.03 (-0.21%)
Omeros (OMER) Worth a Look: Stock Adds 11.8% in Session

Omeros Corporation (OMER) shares rose almost 12% in the last trading session.

BIO : 222.03 (-0.21%)
OMER : 24.95 (-2.96%)
What Falling Estimates & Price Mean for Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals (EGRX) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

EGRX : 83.16 (+1.81%)
BIO : 222.03 (-0.21%)
Bio-Rad Laboratories Has Returned 57.7% Since SmarTrend Recommendation (BIO)

SmarTrend identified an Uptrend for Bio-Rad Laboratories (NYSE:BIO) on July 12th, 2016 at $144.77. In approximately 11 months, Bio-Rad Laboratories has returned 57.69% as of today's recent price of $228.30....

BIO : 222.03 (-0.21%)
Imprimis Pharmaceuticals (IMMY) Looks Good: Stock Up 13%

Imprimis Pharmaceuticals, Inc. (IMMY) shares rose over 13% in the last trading session.

IMMY : 3.36 (unch)
BIO : 222.03 (-0.21%)
Five Stocks Rocketing Higher on Huge Momentum

The bears were sent running, screaming towards their caves today as the market started strong and didn???t look back at all

COL : 104.03 (-0.87%)
AMAT : 43.37 (-1.63%)
BIO : 222.03 (-0.21%)
WYNN : 137.18 (-0.82%)
ALGN : 152.81 (-0.45%)
Bio-Rad Laboratories Shares Up 52.9% Since SmarTrend's Buy Recommendation (BIO)

SmarTrend identified an Uptrend for Bio-Rad Laboratories (NYSE:BIO) on July 12th, 2016 at $144.77. In approximately 11 months, Bio-Rad Laboratories has returned 52.93% as of today's recent price of $221.41....

BIO : 222.03 (-0.21%)
Bio-Rad Introduces Enhanced Options with its IH-Com Data Management Software for Managing Patient Results with the IH-1000 System

HERCULES, CA--(Marketwired - May 24, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb), a global provider of life science research and clinical diagnostic products, today announced that it has...

BIO : 222.03 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials,...

See More

Support & Resistance

2nd Resistance Point 225.23
1st Resistance Point 223.86
Last Price 222.03
1st Support Level 221.50
2nd Support Level 220.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.